What will happen to tetraphases stock? Upon the closing of the transactions, Tetraphase will become a wholly owned subsidiary of La Jolla, and shares of Tetraphase’s common stock will no longer be listed on any public market. Subject to certain limited exceptions, the CVRs will be non-transferable.Who are tetraphases legal and financial advisors? Janney Montgomery Scott is acting as financial advisor to Tetraphase and has rendered a fairness opinion to Tetraphase’s board of directors in connection with the transaction. Wilmer Cutler Pickering Hale and Dorr LLP is acting as legal advisor to Tetraphase in connection with the transaction.Does la jolla own any shares in tetraphase? Additionally, La Jolla owns shares in Tetraphase that represent approximately 15% of Tetraphase’s outstanding voting power. On June 24, 2020, Tetraphase terminated its previously announced merger agreement with Melinta Therapeutics, Inc., dated as of June 4, 2020, in order to enter into the definitive merger agreement with La Jolla.
Phone Number 6179263557 Capitalizing on breakthrough synthetic chemistry, Tetraphase Pharmaceuticals is leveraging a dynamic drug engine targeted at several significant disease categories. Lists Featuring This Company New England Biotechnology Companies 1,929 Number of Organizations • $107.6B Total Funding Amount • 5,944 Number of Investors
Tetraphase Pharmaceuticals Inc located in Watertown, MA 02472 operates in SIC Code 2834 and NAICS Code 325412
Real-time exchange rate quote of N/A including detailed information, live chart and news, profile and other market data.